Jean Baptiste Micol, MD, PhD, Gustave Roussy, Villejuif, France, discusses clonal hematopoesis and how it can inform screening and surveillance approaches. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.